Zhonglei Wang

10PUBLICATIONS
2CO-AUTHORS
Biologically active moleculesNanomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 16, 2026
Small-Molecule Drugs Approved by the FDA in 2025.

|Sep 24, 2026
TRAIL of Hope: Bioactive Dietary Component-Driven Carrier-Free Nanoplatforms for Synergistically Enhanced Tumor Multimodal Therapy.

|Dec 24, 2025
The Ballet of Natural-Product: Carrier-Free "Triadic" Drug Delivery Platforms for Enhanced Tumor Treatment.

Liyan Yang, Zhonglei Wang

|May 28, 2025
Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024.

|Sep 28, 2023
Stand Up to Stand Out: Natural Dietary Polyphenols Curcumin, Resveratrol, and Gossypol as Potential Therapeutic Candidates against Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Zhonglei Wang, Xian-Qing Song, Wenjing Xu

|Aug 12, 2023
The Therapeutic Potential of Natural Dietary Flavonoids against SARS-CoV-2 Infection.

Zhonglei Wang, Liyan Yang

Pageof 2

Frequent Collaborators

5 joint publications

Liyan Yang

1 joint publications

Xian-Qing Song